Ken Jefferd

Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA.

Part of Perrigo Co. Plc, Elan Drug Delivery, Inc. is engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use. The company is based in King Of Prussia, PA.

Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Huawei Technologies Co., Ltd. engages in the manufacture of information and communications technology infrastructure and smart devices. The firm offers consumer products including phones, laptops, tablets, wearables, audio, routers, EMUI user interface, and other related accessories. It also provides business products and services such as carrier network, enterprise wireless and networking, cloud, intelligent computing, data storage, services and software for carrier networks, smart services for enterprises, and cloud migration. The company was founded by Zheng Fei Ren on September 15, 1987 and is headquartered in Shenzhen, China.

Motor Trades Assoc of Australia Superannuation Fund Pty Ltd. operates as a trust company. It is the national industry-based superannuation fund for the motor trades and allied industries and is open to all Australians. The company was founded in 1989 and is headquartered in Barton, Australia.

The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania.

Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA

Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD.

SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA.

AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Citywide Service Solutions Pty Ltd. engages in the provision of open space, environmental and civil infrastructure services. It offers arboriculture and trees, civil services, commercial waste, horticulture and open space, LGA capital works, traffic management, and utilities and infrastructure services. The company was founded in 1995 and is headquartered in North Melbourne, Australia.

Part of Huawei Investment & Holding Co. Ltd. Trade Union Committee, Huawei Technologies Australia Pty Ltd. is an Australian company that distributes telecommunication equipment. The company is based in Melbourne, Australia.

FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona.

The Fred Hollows Foundation (UK) is an international development organization that aims to eliminate avoidable blindness and improve Indigenous Australian health. The non-profit company is based in London, UK and was founded in 1992 by Fred Hollows and Gabi Hollows. The foundation's strategy focuses on caring for some of the world's most disadvantaged people who suffer from vision impairment or blindness due to their place of birth. The British company is committed to raising awareness about the prevalence of avoidable blindness and providing high-quality eye care to disadvantaged communities. The foundation's annual reports showcase the impact of their programs worldwide.

Orthogon Therapeutics LLC is a privately held R&D firm that specializes in drug discovery and development. The company is based in Canton, MA. The company is headquartered in the biotech hub of Greater Boston and has a branch in Leuven. Orthogon uses an innovative structure-based and biophysics platform to design novel medicines. The company's portfolio of infectious disease assets includes antiviral therapeutics, with a lead program being a first-in-class, orally administrable small molecule inhibitor of BK virus replication. Orthogon has secured over $12.50m in investment to date and has additional discovery programs, including a treatment for antibiotic-resistant bacterial infections. The company was founded by Ali Munawar, a veteran biotech entrepreneur, and experienced drug discovery scientists with a mission to prolong and improve patient quality of life.

Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021.